Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREDICTOR: Pre-operative Afatinib in HNSCC
NCT01415674Phase 2Completed
- Sponsor
- Unicancer
- Start
- Jan 2012
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of afatinib in head and neck squamous cell carcinoma (HNSCC), sponsored by Unicancer. Started Jan 2012; status: completed.
02
Drugs
afatinib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT01415674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01415674.